SCHEMBL22639426

SCHEMBL22639426

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5c(-c6ccc(-n7c8ccccc8c8ccccc87)cc6)ccc6ccccc56)cc4)n3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 3/20 0.42
▸ L3MBTL1 Q9Y468 3/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ KMT2A Q03164 3/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ MAPT P10636 3/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ ALOX5 P09917 1/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22639494 0.99 L3MBTL1 (0.44) ATML3MBTL1KDM4EKMT2AHDAC4
SCHEMBL22639431 0.94 KDM4E (0.38) ATML3MBTL1KDM4EKMT2AHDAC4
SCHEMBL23319005 0.94 L3MBTL1 (0.44) ATML3MBTL1KDM4EKMT2AHDAC4
SCHEMBL22639382 0.93 ATM (0.39) ATML3MBTL1KDM4EKMT2AHDAC4
SCHEMBL22639425 0.92 KDM4E (0.38) ATML3MBTL1KDM4EKMT2AHDAC4
SCHEMBL22639390 0.91 KDM4E (0.40) ATML3MBTL1KDM4EKMT2AHDAC4
SCHEMBL25679966 0.90 ATM (0.41) ATML3MBTL1KDM4EKMT2AHDAC4
SCHEMBL24824200 0.90 KDM4E (0.36) ATML3MBTL1KDM4EKMT2AHDAC4
SCHEMBL24787784 0.88 KDM4E (0.39) ATML3MBTL1KDM4EKMT2AHDAC4
SCHEMBL18819388 0.87 L3MBTL1 (0.41) ATML3MBTL1KDM4EKMT2AHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10833278-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2020-11-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10833278-B2 Compound and organic light emitting device comprising the same CRY1, CRY2, ORC3 ATM 2733/4885L3MBTL1 1353/4885KDM4E 2260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback